Challenges in Optimizing Nanoplatforms Used for Local and Systemic Delivery in the Oral Cavity
In this study, we focused on innovative approaches to improve drug administration in oral
pathology, especially by transmucosal and transdermal pathways. These improvements …
pathology, especially by transmucosal and transdermal pathways. These improvements …
New insights into the role of the oral leukoplakia microenvironment in malignant transformation
WA González-Arriagada, G Canedo-Marroquin… - Frontiers in Oral …, 2024 - frontiersin.org
Oral leukoplakia is the most frequent and potentially malignant lesion of the oral cavity.
Although dysplasia grading remains the main factor for risk assessment, challenges persist …
Although dysplasia grading remains the main factor for risk assessment, challenges persist …
Comprehensive insights into oral squamous cell carcinoma: diagnosis, pathogenesis, and therapeutic advances
D Jagadeesan, KV Sathasivam, NK Fuloria… - … -Research and Practice, 2024 - Elsevier
Oral squamous cell carcinoma (OSCC) is considered the most common type of head and
neck squamous cell carcinoma (HNSCC) as it holds 90% of HNSCC cases that arise from …
neck squamous cell carcinoma (HNSCC) as it holds 90% of HNSCC cases that arise from …
Tumor initiation and early tumorigenesis: molecular mechanisms and interventional targets
S Zhang, X Xiao, Y Yi, X Wang, L Zhu, Y Shen… - … and Targeted Therapy, 2024 - nature.com
Tumorigenesis is a multistep process, with oncogenic mutations in a normal cell conferring
clonal advantage as the initial event. However, despite pervasive somatic mutations and …
clonal advantage as the initial event. However, despite pervasive somatic mutations and …
A Review of Immunotherapy for Head and Neck Cancer
JW Goetz, G Rabinowits, N Kalman… - Journal of Dental …, 2024 - journals.sagepub.com
The introduction of immune checkpoint inhibitors (ICIs) to oncological care has transformed
the management of various malignancies, including head and neck squamous cell …
the management of various malignancies, including head and neck squamous cell …
Localized intratumoral delivery of immunomodulators for oral cancer and oral potentially malignant disorders
Immunotherapy has developed into an important modality of modern cancer treatment.
Unfortunately, checkpoint inhibitor immunotherapies are currently delivered systemically …
Unfortunately, checkpoint inhibitor immunotherapies are currently delivered systemically …
Oral Pre-malignancy: An Update on Novel Therapeutic Approaches
S Naara, C Andrews, A Sikora, M Williams… - Current Oncology …, 2024 - Springer
Abstract Purpose of Review This review aims to provide a comprehensive overview of the
current advances in managing and preventing progression of oral potentially malignant …
current advances in managing and preventing progression of oral potentially malignant …
[HTML][HTML] A Bibliometric and Visualised Analysis of Proliferative Verrucous Leucoplakia From 2003 to 2023
L Zhu, L Ou, Y Yang, D Zhao, B Liu, R Liu, O Liu… - International Dental …, 2024 - Elsevier
Background Proliferative verrucous leucoplakia (PVL) is a rare but slow-growing, aggressive
leucoplakia lesion associated with the highest malignant transformation rate in oral …
leucoplakia lesion associated with the highest malignant transformation rate in oral …
[HTML][HTML] Adhesive lipophilic gels delivering rapamycin prevent oral leukoplakia from malignant transformation
Y Du, T Liu, T Ding, X Zeng, Q Chen, H Zhao - Materials Today Bio, 2024 - Elsevier
Oral leukoplakia (OLK) is the most emblematic oral potentially malignant disorder that may
precede the diagnosis of oral squamous cell carcinoma (OSCC) and has an overall …
precede the diagnosis of oral squamous cell carcinoma (OSCC) and has an overall …
Chemoprevention of head and neck cancer: a review of current approaches and future perspectives
S Han, R Bommireddy, P Kim, P Selvaraj… - Cancer Prevention …, 2024 - aacrjournals.org
Head and neck squamous cell carcinoma (HNSCC) is a spectrum of heterogeneous
malignancies. A variety of genetic, environmental, and lifestyle factors contribute to the …
malignancies. A variety of genetic, environmental, and lifestyle factors contribute to the …